Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2-Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control Arm The smart functionality of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results